S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Free Stock Analysis Report: See The True Value of Any Stock (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NASDAQ:ZLAB

Zai Lab - ZLAB Price Target & Analyst Ratings

$31.46
+0.82 (+2.68%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$30.75
▼
$33.80
50-Day Range
$30.21
▼
$47.62
52-Week Range
$20.98
▼
$53.95
Volume
600,425 shs
Average Volume
809,461 shs
Market Capitalization
$3.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$95.25

Zai Lab Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 3 Analyst Ratings

Consensus Analyst Price Target

$95.25
202.77% Upside
High Prediction$127.00
Average Prediction$95.25
Low Prediction$70.00
TypeCurrent
3/24/22 to 3/24/23		1 Month Ago
2/22/22 to 2/22/23		3 Months Ago
12/24/21 to 12/24/22		1 Year Ago
3/24/21 to 3/24/22
Consensus Rating
Buy
Buy
Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
5 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$95.25$97.50$90.80$165.71
Predicted Upside202.77% Upside177.43% Upside133.21% Upside101.03% Upside
Get Zai Lab Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter.

ZLAB Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ZLAB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Zai Lab Stock vs. The Competition

TypeZai LabMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.64
2.47
Consensus RatingBuyBuyHold
Predicted Upside202.77% Upside1,988.84% Upside24.71% Upside
News Sentiment RatingNeutral News
Neutral News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/16/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight$79.00 ➝ $70.00+104.26%
11/11/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy$199.00 ➝ $127.00+317.90%
10/20/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$83.00+193.18%
4/21/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		J. Chang
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower TargetOutperform$102.00 ➝ $101.00+135.27%
1/21/2022Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$64.00+22.61%
10/12/2021Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform
4/13/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$205.73 ➝ $211.23+32.14%
2/8/2021Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$130.00 ➝ $225.00+26.75%
(Data available from 3/24/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












ZLAB Price Target - Frequently Asked Questions

What is Zai Lab's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Zai Lab stock is Buy based on the current 3 buy ratings for ZLAB. The average twelve-month price prediction for Zai Lab is $95.25 with a high price target of $127.00 and a low price target of $70.00. Learn more on ZLAB's analyst rating history.

Do Wall Street analysts like Zai Lab more than its competitors?

Analysts like Zai Lab more than other Medical companies. The consensus rating score for Zai Lab is 3.00 while the average consensus rating score for medical companies is 2.64. Learn more on how ZLAB compares to other companies.

Does Zai Lab's stock price have much upside?

According to analysts, Zai Lab's stock has a predicted upside of 173.83% based on their 12-month price targets.

What analysts cover Zai Lab?

Zai Lab has been rated by JPMorgan Chase & Co. in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (NASDAQ:ZLAB) was last updated on 3/24/2023 by MarketBeat.com Staff